Medical network - December 30 December 29, learns from the ministry of commerce, the national medicine circulation industry development plan (2016-2020), put forward planning, by 2020, basic medicine circulation industry development to adapt to build a well-off society in an all-round way of the overall goal and the people's growing health needs, forming a unified open, competitive and orderly, centering on network layout optimization, high efficiency, safety, convenience and circulation, the masses benefit from modern medicine circulation system.
Planning also determine specific objectives, forming a group network covering the whole country, intensive and informationization level higher large medicine circulation enterprises. Pharmaceutical wholesale enterprises with annual sales accounted for more than 90% of the total pharmaceutical wholesale market; Pharmaceutical retail enterprises with annual sales accounted for over 40% of the total amount of medicine retail market; Rate of drug retail chain of more than 50%.
Planning is put forward, to improve industry concentration. Encourage medicine circulation enterprises through merger and reorganization, the listed financing, issuing bonds and other way to do strong, do big, speed up the implementation scale, intensive and modern management. Support the development of small and medium-sized pharmaceutical circulation enterprises procurement alliance and pharmacy alliance, using 聯購 distribution, unified distribution, reduce operating costs, improve the organizational level. Encourage a zero integration, chaining operation, development of multiple formats of mixed operation.
Planning is also proposed, improve circulation management level, make modern medical providers. Optimization of drug supply chain management. Support medicine circulation enterprises to strengthen supply chain management, improve the supply chain integration system, to provide supply chain upstream and downstream market development, price negotiation, online payment, financial support and other value-added services and integrated solutions, accelerate the development of transforming to pharmaceutical supply chain service provider. Use of cloud computing, big data and other modern information technology, integration of drug research and development production, circulation use, disease changes and patients' health demand and consumption habits of data information, strengthen the management of big data, analysis and application, for drug research and development institutions, judge the trend of the market, adjust the product structure and production enterprise medical institutions to improve drug choice, strengthen the rational use of drugs, to provide valuable data to support, improve the operation efficiency of the whole supply chain.
Planning, stressed that "Internet + medicine circulation". To promote information technology such as mobile Internet, Internet of things is widely used in the field of drug circulation, encourage enterprises to carry out the service innovation based on the Internet, the drug circulation channel and development pattern. Support drug distribution enterprises and medical institutions and health care department, e-commerce enterprises to carry out the medical electrical business services, provide patients with over-the-counter "net book (medicine) shop", "net book (medicine) shop" and convenient services, promote the development of online fusion.
Planning also support the development of foreign enterprises. Support medicine circulation enterprises to carry out various forms of international exchanges and cooperation, participate in the pharmaceutical supply chain of international division of labor, enhance the level of internationalization. Service country "area" strategy, and actively develop "neighbourhood" all the way along the national pharmaceutical market, to carry out medical investment cooperation with relevant countries. Give full play to the medicine, the role of exhibition economy in exploring international market, promote the international domestic enterprise visibility and reputation. To build international cooperation platform, and actively participate in global public health aid. Promote the establishment of international standards and certification system of traditional Chinese medicine, to expand international market access of Chinese medicine through multilateral negotiation. Vigorously develop trade in services of traditional Chinese medicine to cure with medicine, expanding the size of the market of traditional Chinese medicine in our country, improve the international influence of Chinese medicine.
According to statistics, China pharmaceutical electricity has six consecutive years of strong growth. Kang CMH data indicates that there are 2016 online pharmacies all category deals is expected to reach 16 billion yuan, up 45.5% from a year earlier, drug single rose to 4 billion yuan. A shares in nine Ann medical, kyushu and other listed companies, involving medical related business wisdom. |
